Material transfer agreement with UCSF

October 08th, 2019 | Press Release

We have entered a collaborative research (MTA) agreement with Professor Hideho Okada, Neurological Surgery, the University of California, San Francisco on cancer immunotherapy using T-ignite® technology.

Back to Press releases

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Google Analytics« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.